Macter International Limited (PSX:MACTER)
Pakistan
· Delayed Price · Currency is PKR 281.45
-13.28 (-4.51%)
At close: Mar 6, 2026
Macter International Revenue
Macter International had revenue of 3.51B PKR in the quarter ending December 31, 2025, with 21.57% growth. This brings the company's revenue in the last twelve months to 11.58B, up 24.42% year-over-year. In the fiscal year ending June 30, 2025, Macter International had annual revenue of 10.36B with 29.91% growth.
Revenue (ttm)
11.58B
Revenue Growth
+24.42%
P/S Ratio
1.17
Revenue / Employee
9.04M
Employees
1,282
Market Cap
13.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10.36B | 2.39B | 29.91% |
| Jun 30, 2024 | 7.97B | 1.05B | 15.14% |
| Jun 30, 2023 | 6.93B | 1.31B | 23.42% |
| Jun 30, 2022 | 5.61B | 239.05M | 4.45% |
| Jun 30, 2021 | 5.37B | -331.94M | -5.82% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ferozsons Laboratories | 22.22B |
| Citi Pharma | 14.10B |
| Otsuka Pakistan | 4.26B |
| Highnoon Laboratories | 26.61B |
| The Searle Company | 33.26B |
| AGP Limited | 27.73B |
| Abbott Laboratories (Pakistan) | 74.84B |
| GlaxoSmithKline Pakistan | 62.07B |